Vascular endothelial-derived Von Willebrand factor inhibits lung cancer progression through the αvβ3/ERK1/2 axis

MLA

Yuxin Lu, et al. “Vascular Endothelial-Derived Von Willebrand Factor Inhibits Lung Cancer Progression through the Αvβ3/ERK1/2 Axis.” Toxicology and Applied Pharmacology, vol. 468, June 2023, p. 116516. EBSCOhost, https://doi.org/10.1016/j.taap.2023.116516.

APA

Yuxin Lu, Yingxue Qi, Jiayi Gu, Qianying Tao, Yifei Zhu, Haibin Zhang, & Xin Liang. (2023). Vascular endothelial-derived Von Willebrand factor inhibits lung cancer progression through the αvβ3/ERK1/2 axis. Toxicology and Applied Pharmacology, 468, 116516. https://doi.org/10.1016/j.taap.2023.116516

Chicago

Yuxin Lu, Yingxue Qi, Jiayi Gu, Qianying Tao, Yifei Zhu, Haibin Zhang, and Xin Liang. 2023. “Vascular Endothelial-Derived Von Willebrand Factor Inhibits Lung Cancer Progression through the Αvβ3/ERK1/2 Axis.” Toxicology and Applied Pharmacology 468 (June): 116516. doi:10.1016/j.taap.2023.116516.